Cortechs.ai

Cortechs.ai is a commercial-stage AI diagnostics company specializing in quantitative medical imaging software for neurology and oncology. Founded in 2017, it commercializes technology with roots dating back to 1996, establishing its NeuroQuant® product as a clinical standard for brain MRI volumetry. The company has achieved significant commercial traction with over 1,400 hospitals and imaging centers as customers across 44 countries. Its strategy focuses on expanding its software suite, securing reimbursement via new CPT codes, and leveraging partnerships with major imaging equipment manufacturers.

AI/ML platform for automated medical image segmentation and volumetric analysis, featuring a normative database for comparison against age/sex-matched controls.

Cortechs.ai competes in the crowded medical imaging AI market. Direct competitors include other specialized neuro-AI companies (e.g., icometrix, Viz.ai for stroke) and broader platform AI vendors. Its main advantages are its long clinical heritage, FDA-cleared products, large normative database, and established integrations with major imaging OEMs. Competition also comes from hospitals developing in-house solutions and OEMs building native AI into their scanners.